BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹150 Cr | ₹140 Cr | ₹131 Cr | ₹104 Cr | ₹110 Cr |
What is the latest Total Debt ratio of BAL PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹150 Cr |
| Mar2024 | ₹140 Cr |
| Mar2023 | ₹131 Cr |
| Mar2022 | ₹104 Cr |
| Mar2021 | ₹110 Cr |
How is Total Debt of BAL PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹150 Cr | 7.72 | |
| Mar2024 | ₹140 Cr | 6.56 | |
| Mar2023 | ₹131 Cr | 26.40 | |
| Mar2022 | ₹104 Cr | -5.80 | |
| Mar2021 | ₹110 Cr | - | |
Compare Total Debt of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹106.6 Cr | -4.9% | -9.6% | -41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -4.9% |
-9.6% |
-41.3% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses